| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |